From: Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report
Date | Route | CD34 | MSC |
---|---|---|---|
Cycle 1 | |||
Oct 31 2008 | IT | 3 million | 6 million |
Nov 11 2008 | IT | 3 million | 6 million |
Nov 14 2008 | IT | 3 million | 6 million |
Nov 18 2008 | IT | 3 million | 6 million |
Nov 20 2008 | IT | 3 million | 6 million |
Cycle 2 | |||
Jan 21 2009 | IT | 3 million | 6 million |
Jan 23 2009 | IT | 3 million | 6 million |
Jan 26 2009 | IT | 3 million | 7 million |
Jan 28 2009 | IT | 3 million | 7 million |
Jan 30 2009 | IT | 3 million | 7 million |
Cycle 3 | |||
Jul 1 2009 | IT | 1.5 million | 5.7 million |
Jul 3 2009 | IT | 1.5 million | 6.3 million |
July 6 2009 | IT | 1.5 million | 6.3 million |
 | IV | 1.5 million | 3.9 million |
July 8 2009 | IT | 1.5 million | 6.12 million |
 | IV | 1.5 million | 3.9 million |
July 10 2009 | IT | 1.5 million | 6.12 million |